Coronary thrombolysis by intravenous infusion of recombinant single chain urokinase-type plasminogen activator or recombinant urokinase in baboons: Effect on regional blood flow, infarct size and hemostasis
- 1 July 1986
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 8 (1) , 118-124
- https://doi.org/10.1016/s0735-1097(86)80101-2
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Coronary thrombolysis in dogs with intravenously administered human pro-urokinase.Circulation, 1985
- Human tissue-type plasminogen activator: from the laboratory to the bedside.Circulation, 1985
- Coronary thrombolysis and infarct size reduction after intravenous infusion of recombinant tissue-type plasminogen activator in nonhuman primates.Journal of Clinical Investigation, 1985
- Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species.Journal of Clinical Investigation, 1984
- Quantification of collateral resistance in acute and chronic experimental coronary occlusion in the dog.Circulation Research, 1976
- Coronary artery reperfusion: Effects of occlusion duration on reactive hyperemia responsesBasic Research in Cardiology, 1975
- The “No-Reflow” Phenomenon after Temporary Coronary Occlusion in the DogJournal of Clinical Investigation, 1974
- The distribution of myocardial flowBasic Research in Cardiology, 1974
- Some sources of error in measuring regional blood flow with radioactive microspheres.Journal of Applied Physiology, 1971